A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Goldsmith, D R, Rapaport, M H, Miller, B J·2016·Molecular Psychiatry

Cited by (1,002)

Items 501–600 of 1,002

  1. Human umbilical cord-derived mesenchymal stem cells alleviate schizophrenia-relevant behaviors in amphetamine-sensitized mice by inhibiting neuroinflammation
    Min‐Jung You, Minji Bang, Hyuntae Park, Bohyun Yang, Kyu Beom Jang, Jongman Yoo, Dong‐Youn Hwang, MinYoung Kim, Borah Kim, Sang‐Hyuk Lee et al. · 2020 · Translational Psychiatry
  2. Inflammation, hippocampal volume, and cognition in schizophrenia: results from the Northern Finland Birth Cohort 1966
    Brian J. Miller, Karl‐Heinz Herzig, Jari J. Jokelainen, Toni Karhu, Sirkka M Keinanen-Kiukaanniemi, Marjo‐Riitta Järvelin, Juha M. Veijola, Heimo T. Viinamäki, Päivikki Tanskanen, Erika Jääskeläinen et al. · 2020 · European Archives of Psychiatry and Clinical Neuroscience
  3. Blood cytokines differentiate bipolar disorder and major depressive disorder during a major depressive episode: Initial discovery and independent sample replication
    Emanuela Martinuzzi, Susana Barbosa, Philippe Courtet, Émilie Olié, Sébastien Guillaume, El Chérif Ibrahim, Douglas Daoudlarian, Laëtitia Davidovic, Nicolas Glaichenhaus, Raoul Belzeaux-R · 2021 · Brain Behavior & Immunity - Health
  4. Major depression favors the expansion of Th17-like cells and decrease the proportion of CD39+Treg cell subsets in response to myelin antigen in multiple sclerosis patients
    Priscila M. Sacramento, Marisa C. Sales, Taissa de Matos Kasahara, Clarice Monteiro, Hugo A. A. Oyamada, Aleida Dias, Lana M. Lopes, Camilla Castro, Átila Duque Rossi, Lucas Matos Millioni et al. · 2022 · Cellular and Molecular Life Sciences
  5. Association of DNA Methylation of the NLRP3 Gene with Changes in Cortical Thickness in Major Depressive Disorder
    Kyu‐Man Han, Kwan Woo Choi, Aram Kim, Wooyoung Kang, Youbin Kang, Woo‐Suk Tae, Mi-Ryung Han, Byung‐Joo Ham · 2022 · International Journal of Molecular Sciences
  6. State-dependent increase in the levels of neurotrophin-3 and neurotrophin-4/5 in patients with bipolar disorder: A meta-analysis
    Ping‐Tao Tseng, Yen‐Wen Chen, Kun-Yu Tu, Hung‐Yu Wang, Weilun Chung, Ching-Kuan Wu, Shih‐Pin Hsu, Hung-Chang Kuo, Pao‐Yen Lin · 2016 · Journal of Psychiatric Research
  7. Longitudinal population subgroups of CRP and risk of depression in the ALSPAC birth cohort
    Osimo, Emanuele F., Stochl, Jan, Zammit, Stan, Lewis, Glyn, Jones, Peter B., Khandaker, Golam M. · 2020 · Comprehensive Psychiatry
  8. White matter integrity and pro-inflammatory cytokines as predictors of antidepressant response in MDD
    Sigrid Breit, Elena A. Mazza, Sara Poletti, Francesco Benedetti · 2023 · Journal of Psychiatric Research
  9. Microbiome and immuno-metabolic dysregulation in patients with major depressive disorder with atypical clinical presentation
    Alexander Refisch, Zümrüt Duygu Şen, Tilman E. Klassert, Anne Busch, Bianca Besteher, Lena Vera Danyeli, Dario Lucas Helbing, Ulrike Schulze‐Späte, Andreas Stallmach, Michael W Bauer et al. · 2023 · Neuropharmacology
  10. The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings
    Adriano José Maia Chaves Filho, Capri Eyres, Leonie Blöbaum, Antonia Landwehr, Marie‐Ève Tremblay · 2024 · Journal of Neurochemistry
  11. To be blamed or pitied? The effect of illness on social behavior, cytokine levels and feed intake in undocked boars
    Camilla Munsterhjelm, Janicke Nordgreen, Frida Aae, Mari Heinonen, Kristin Olstad, Torunn Aasmundstad, Andrew Michael Janczak, Anna Valros · 2017 · Physiology & Behavior
  12. Overlapping mechanisms linking insulin resistance with cognition and neuroprogression in bipolar disorder
    Ari B. Cuperfain, James L. Kennedy, Vanessa Faria Gonçalves · 2020 · Neuroscience & Biobehavioral Reviews
  13. A Reciprocal Link Between Gut Microbiota, Inflammation and Depression: A Place for Probiotics?
    Ahmed Eltokhi, Iris E. Sommer · 2022 · Frontiers in Neuroscience
  14. Altered serum adiponectin and interleukin-8 levels are associated in the pathophysiology of major depressive disorder: A case-control study
    Salsabil Islam, Towhidul Islam, Zabun Nahar, Mohammad Shahriar, Sardar Mohammad Ashraful Islam, Mohiuddin Ahmed Bhuiyan, Md. Rabiul Islam · 2022 · PLoS ONE
  15. Association of preexisting psychiatric disorders with post-COVID-19 prevalence: a cross-sectional study
    Mayumi Kataoka, Megumi Hazumi, Kentaro Usuda, Emi Okazaki, Daisuke Nishi · 2023 · Scientific Reports
  16. The Future of DSM : Role of Candidate Biomarkers and Biological Factors
    Bruce N. Cuthbert, Olusola Ajilore, Jonathan E. Alpert, Diana E. Clarke, Wilson M. Compton, Karen P. G. Drexler, Kenneth Po-Lun Fung, Nitin Gogtay, Martien J. Kas, Anand Kumar et al. · 2026 · American Journal of Psychiatry
  17. Blood cytokines in major depressive disorder in drug-naïve adolescents: A systematic review and meta-analysis
    Kaustubh Kishor Jadhav, Joud Daouk, Karoliina Kurkinen, Siiri‐Liisi Kraav, Päivi Eriksson, Tommi Tolmunen, Katja M. Kanninen · 2024 · Journal of Affective Disorders
  18. The Relationship Between Neuroimmunity and Bipolar Disorder: Mechanism and Translational Application
    Zhiang Niu, Lu Yang, Xiaohui Wu, Yuncheng Zhu, Jun Chen, Yiru Fang · 2019 · Neuroscience Bulletin
  19. Pharmacological strategies for the management of comorbid depression and schizophrenia
    Eva Češková · 2020 · Expert Opinion on Pharmacotherapy
  20. Neuroimmune Mechanisms and Sex/Gender-Dependent Effects in the Pathophysiology of Mental Disorders
    Alexandros G. Kokkosis, Stella E. Tsirka · 2020 · Journal of Pharmacology and Experimental Therapeutics
  21. Towards precision medicine: What are the stratification hypotheses to identify homogeneous inflammatory subgroups
    Magdalini Ioannou, Marianne Foiselle, Jasmina Mallet, Elissa L. Stam, Ophélia Godin, Caroline Dubertret, Emilie Terro, Iris E. Sommer, Bartholomeus C. M. Haarman, Marion Leboyer et al. · 2020 · European Neuropsychopharmacology
  22. Pharmacotherapy of schizophrenia: Mechanisms of antipsychotic accumulation, therapeutic action and failure
    Daria Chestnykh, Davide Amato, Johannes Kornhuber, Christian P. Müller · 2021 · Behavioural Brain Research
  23. A multisystem composite biomarker as a preliminary diagnostic test in bipolar disorder
    Klaus Munkholm, Maj Vinberg, Bente Klarlund Pedersen, Henrik Enghusen Poulsen, Claus Thorn Ekstrøm, Lars Vedel Kessing · 2018 · Acta Psychiatrica Scandinavica
  24. Role of the immune-kynurenine pathway in treatment-resistant schizophrenia
    Wenjin Chen, Yichang Tian, Mengzhuang Gou, Leilei Wang, Jinghui Tong, Yanfang Zhou, Wei Feng, Yanli Li, Song Chen, Yongchang Liu et al. · 2023 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  25. Anti-Oxidative Effects of Melatonin Receptor Agonist and Omega-3 Polyunsaturated Fatty Acids in Neuronal SH-SY5Y Cells: Deciphering Synergic Effects on Anti-Depressant Mechanisms
    Senthil Kumaran Satyanarayanan, Yin-Hwa Shih, Yu-Chuan Chien, Shih‐Yi Huang, Piotr Gałecki, Siegfried F. Kasper, Jane Pei‐Chen Chang, Kuan‐Pin Su · 2018 · Molecular Neurobiology
  26. Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in Schizophrenia
    Tohru Ohnuma, Shohei Nishimon, Mayu Takeda, Takahiro Sannohe, Narimasa Katsuta, Heii Arai · 2018 · Frontiers in Psychiatry
  27. Açaí ( Euterpe oleracea Mart.) presents anti-neuroinflammatory capacity in LPS-activated microglia cells
    Diulie Valente de Souza, Lauren Pappis, THUANY LURA TEIXEIRA BANDEIRA, Gabriela Geraldo Sangoi, Tuyla Fontana, Vitor Braga Rissi, Michele Rorato Sagrillo, Marta Maria Medeiros Frescura Duarte, Thiago Duarte, David Frederick Bodenstein et al. · 2020 · Nutritional Neuroscience
  28. Impact of maternal immune activation on dendritic spine development
    Martyna Pękała, Marta Doliwa, Katarzyna B. Kalita · 2020 · Developmental Neurobiology
  29. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank
    Michael D.E. Sewell, Lorena Jiménez Sánchez, Xueyi Shen, Amelia J. Edmondson-Stait, Claire Green, Mark J. Adams, Olivia M. Rifai, Andrew Mark McIntosh, Donald M. Lyall, Heather Clare Whalley et al. · 2021 · Brain Behavior and Immunity
  30. Impact of antipsychotic treatment on methylation status of Interleukin-6 [IL-6] gene in Schizophrenia
    Deepthi Venugopal, Venkataram Shivakumar, Manjula Subbanna, Sunil V. Kalmady, Anekal C. Amaresha, Sri Mahavir Agarwal, Janardhanan C. Narayanaswamy, Moinak Banerjee, Monojit Debnath, Ganesan Venkatasubramanian · 2018 · Journal of Psychiatric Research
  31. Brain free water alterations in first-episode psychosis: a longitudinal analysis of diagnosis, course of illness, and medication effects
    Joyce Y. Guo, Tyler A. Lesh, Tara A. Niendam, John Daniel Ragland, Laura M. Tully, C. S. Carter · 2020 · Psychological Medicine
  32. The Effects of Peripheral Inflammation on the Brain—A Neuroimaging Perspective
    Caitlin E. Millett, Katherine E. Burdick, Marek R. Kubicki · 2022 · Harvard Review of Psychiatry
  33. Differences in Blood Leukocyte Subpopulations in Schizophrenia
    Leon Dudeck, Madeleine Nussbaumer, Thomas Nickl‐Jockschat, Paul C. Guest, Henrik Dobrowolny, Gabriela Meyer-Lotz, Zhongming Zhao, Roland Jacobs, Kolja Schiltz, Brisa Simões Fernandes et al. · 2025 · JAMA Psychiatry
  34. Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controls
    David R. Goldsmith, Nicholas Massa, Brad D. Pearce, Evanthia C. Wommack, Alaaeddin Alrohaibani, Neha Goel, Bruce N. Cuthbert, Molly Fargotstein, Jennifer C. Felger, Ebrahim Haroon et al. · 2020 · Schizophrenia
  35. Chemokine MCP1 is associated with cognitive flexibility in schizophrenia: A preliminary analysis
    Federica Klaus, Kyle R. Mitchell, Sharon C. Liou, Lisa T. Eyler, Tanya T. Nguyen · 2021 · Journal of Psychiatric Research
  36. Plasma polyunsaturated fatty acids and mental disorders in adolescence and early adulthood: cross-sectional and longitudinal associations in a general population cohort
    David Mongan, Colm Healy, Hannah J Jones, Stanley Zammit, Mary D Cannon, David Cotter · 2021 · Translational Psychiatry
  37. First episode psychosis following receipt of first dose of COVID-19 vaccine: A case report
    Sandeep Grover, Seema Rani, Komal Kohat, Sanjana Kathiravan, Garima Patel, Swapnajeet Sahoo, Aseem Mehra, Shubhmohan Singh, Sanjay Kumar Bhadada · 2022 · Schizophrenia Research
  38. Cytokines as Potential Biomarkers of Clinical Characteristics of Schizophrenia
    Irina A. Mednova, Anastasiia S. Boiko, Elena G. Kornetova, Arkadiy V. Semke, Nikolay A. Bokhan, Svetlana А. Ivanova · 2022 · Life
  39. The future of diagnosis in clinical neurosciences: Comparing multiple sclerosis and schizophrenia
    Błażej Misiak, Jerzy Samochowiec, Krzysztof Kowalski, Wolfgang Gäebel, Claudio L. Bassetti, Andrew Chan, Philip A. P. M. Gorwood, Sergi Papiol, Geert Dom, Umberto Volpe et al. · 2023 · European Psychiatry
  40. Imbalance in amino acid and purine metabolisms at the hypothalamus in inflammation-associated depression by GC-MS
    Yu Hsuan Wu, Yonghong Li, Yanjuan Jia, Chaojun Wei, Hui Xu, Rui Hong Guo, Yuanting Li, Jing Jia, Xiaoming Qi, Xiaoling Gao · 2017 · Molecular BioSystems
  41. Novel Treatment Targets Based on Insights in the Etiology of Depression: Role of IL-6 Trans-Signaling and Stress-Induced Elevation of Glutamate and ATP
    Hans O. Kalkman · 2019 · Pharmaceuticals
  42. Increased interleukin 18 activity in adolescents with early-onset psychosis is associated with cortisol and depressive symptoms
    Kirsten Wedervang‐Resell, Svein Friis, Vera Lonning, Runar Elle Smelror, Cecilie Haggag Johannessen, Elina Johanna Reponen, Siv Hege Lyngstad, Tove Lekva, Pål Aukrust, Thor Ueland et al. · 2019 · Psychoneuroendocrinology
  43. Attention-deficit/hyperactivity disorder: is there a connection with the immune system?
    Pieter J. Hoekstra · 2019 · European Child & Adolescent Psychiatry
  44. Curcumin and nano‐curcumin applications in psychiatric disorders
    Ramin Mohammadzadeh, Marziyeh Fathi, Mohammad Mostafa Pourseif, Yadollah Omidi, Sara Farhang, Mohammad Barzegar-Jalali, Hadi Valizadeh, Ailar Nakhlband, Khosro Adibkia · 2024 · Phytotherapy Research
  45. Extra-axial inflammatory signal and its relationship to peripheral and central immunity in depression
    Brandi Eiff, Edward Thomas Bullmore, Menna Ruth Clatworthy, Tim D. Fryer, Carmine Maria Pariante, Valeria Mondelli, Lucia Maccioni, Nouchine K. Hadjikhani, Marco L. Loggia, Michael A. Moskowitz et al. · 2024 · Brain
  46. A review on shared clinical and molecular mechanisms between bipolar disorder and frontotemporal dementia
    Camila Fernandes Nascimento, Paula Villela Nunes, Roberta Diehl Rodriguez, Leonel Tadao Takada, Cláudia Kimie Suemoto, Lea T. Grinberg, Ricardo Nitríni, Beny Lafer · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  47. Systemic immunization with altered myelin basic protein peptide produces sustained antidepressant-like effects
    Ying Han, Cheng-Yu Sun, Shiqiu Meng, Serik Tabarak, Kai Yuan, Lu Cao, Wei Yan, Lingzhi Xu, Jiahui Deng, Weili Zhu et al. · 2019 · Molecular Psychiatry
  48. The Role of Cytokines in Predicting the Efficacy of Acute Stage Treatment in Patients with Schizophrenia
    Xiaoyan He, Qingyan Ma, Yajuan Fan, Binbin Zhao, Wei Wang, Feng Zhu, Xiancang Ma, Lina Zhou · 2020 · Neuropsychiatric Disease and Treatment
  49. Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)
    Muhammad Ishrat Husain, Clare Cullen, Madeha Umer, Andre F. Carvalho, Stefan M. Kloiber, Jeffrey H. Meyer, Abigail Ortiz, Yuliya Knyahnytska, Muhammed Omair Husain, Justine L. Giddens et al. · 2020 · BMC Psychiatry
  50. Different serum protein factor levels in first‐episode drug‐naive patients with schizophrenia characterized by positive and negative symptoms
    Nan Dai, Huijin Jie, Yong Duan, Peng Xiong, Xiufeng Xu, Chen Peng, Minmin Kang, Ming Li, Ting Li, Zhengyuan Huang et al. · 2020 · Psychiatry and Clinical Neurosciences
  51. Altered structural connectivity and cytokine levels in Schizophrenia and Genetic high-risk individuals: Associations with disease states and vulnerability
    Yang Wang, Yange Wei, Elliot Kale Edmiston, Fay Y. Womer, Xizhe Zhang, Jia Duan, Yue Zhu, Ran Zhang, Zhiyang Yin, Yifan Zhang et al. · 2020 · Schizophrenia Research
  52. An observational study investigating cytokine levels in the cerebrospinal fluid of patients with schizophrenia spectrum disorders
    Kimon Runge, Bernd L. Fiebich, Hanna Kuzior, Soraya Wilke Saliba, Nizar M. Yousif, Sophie Meixensberger, Kathrin Nickel, Dominik Denzel, Miriam A. Schiele, Simon J. Maier et al. · 2021 · Schizophrenia Research
  53. Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric Depression
    Malcolm Forbes, Adrienne E O'Neil, Melissa M. Lane, Bruno Agustini, Nick Myles, Michael Berk · 2021 · Drugs & Aging
  54. Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study
    John Abel Engh, Thor Ueland, Ingrid Agartz, Dimitrios Andreou, Pål Aukrust, Birgitte Boye, Erlend Bøen, Ole Kristian Drange, Torbjørn Elvsåshagen, Sigrun Hope et al. · 2021 · Schizophrenia Bulletin
  55. Role of amygdala in stress-induced upregulation of airway IL-1 signaling in asthma
    Melissa A. Rosenkranz, Stephane J. Esnault, Lauren K. Gresham, Richard J. Davidson, Bradley T. Christian, Nizar N. Jarjour, William W. Busse · 2021 · Biological Psychology
  56. Correlation of BDNF , VEGF , TNF ‐α, and S100B with cognitive impairments in chronic, medicated schizophrenia patients
    Phatcharee Chukaew, Nutthaya Bunmak, Natchaphon Auampradit, Apinya Siripaiboonkij, Witchuda Saengsawang, Woraphat Ratta‐apha · 2022 · Neuropsychopharmacology Reports
  57. Inflammatory markers and depression in Parkinson’s disease: a systematic review
    Luís Guilherme Ramanzini, Luís Fernando Muniz Camargo, Juliana Oliveira Freitas Silveira, Guilherme Vargas Bochi · 2022 · Neurological Sciences
  58. Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis – Results of the randomized controlled Vienna omega-3 study
    Stefan Smesny, Berko Milleit, Miriam R. Schaefer, Jana Hesse, Monika Schlögelhofer, Kerstin Langbein, Uta‐Christina Hipler, Maximus Berger, David Cotter, Heinrich Sauer et al. · 2017 · Schizophrenia Research
  59. Could a blood test for PTSD and depression be on the horizon?
    Dario Aspesi, Graziano Pinna · 2018 · Expert Review of Proteomics
  60. Interleukin 6 as a pathogenic factor mediating clinical manifestations and a therapeutic target for rheumatic diseases and depressive disorders
    Tatyana Andreyevna Lisitsyna, Dmitry Yu. Veltishchev, Aleksander M. Lila, Evgeny Lvovich Nasonov · 2019 · Rheumatology Science and Practice
  61. Infections, antibiotic treatment and the Microbiome in relation to schizophrenia
    Amalie Wandel Klein‐Petersen, Ole Köhler‐Forsberg, Michael E. Benros · 2019 · Schizophrenia Research
  62. Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function
    Heikki Laurikainen, Arja Vuorela, Anna Toivonen, Linnea Reinert‐Hartwall, Kalevi Trontti, Maija Lindgren, Jaakko Keinänen, Teemu J.S. Mäntylä, Janina Paju, Tuula Ilonen et al. · 2020 · Translational Psychiatry
  63. Impact of neuroinflammation on brain glutamate and dopamine signalling in schizophrenia: an update
    Usha Y. Nayak, Jyothsna Manikkath, Devinder S Arora, Jayesh Mudgal · 2025 · Metabolic Brain Disease
  64. Peripheral Immune-Inflammatory Pathways in Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: Exploring Their Potential as Treatment Targets
    Abbas Firras Almulla, Michael H. J. Maes · 2025 · CNS Drugs
  65. N-3 PUFA diet enrichment prevents amyloid beta-induced depressive-like phenotype
    Maria Grazia Morgese, Stefania Schiavone, Emanuela Mhillaj, María Bové, Paolo Tucci, Luigia Trabace · 2017 · Pharmacological Research
  66. Prolonged Periods of Social Isolation From Weaning Reduce the Anti-inflammatory Cytokine IL-10 in Blood and Brain
    Fabiana Maria das Graças Corsi Zuelli, Helene Fachim, Camila Marcelino Loureiro, Rosana Shuhama, Giuliana Bertozi, Sâmia R.L. Joca, Paulo Rossi Menezes, Paulo Louzada‐Júnior, Cristina Marta Del‐Ben · 2019 · Frontiers in Neuroscience
  67. Hidradenitis suppurativa and schizophrenia: a nationwide cohort study
    Dana Tzur Bitan, Daniella Berzin, Arnon Dov Cohen · 2019 · Journal of the European Academy of Dermatology and Venereology
  68. State-of-the-Art: Inflammatory and Metabolic Markers in Mood Disorders
    Federico Mucci, Donatella Marazziti, Alessandra Della Vecchia, Stefano Baroni, Paolo Morana, Barbara Carpita, Paola Mangiapane, Florinda Morana, Benedetto Morana, Liliana Dell’Osso · 2020 · Life
  69. Proinflammatory Cytokines Predict Brain Metabolite Concentrations in the Anterior Cingulate Cortex of Patients With Bipolar Disorder
    Sara Poletti, Mario Gennaro Mazza, Benedetta Vai, Cristina Lorenzi, Cristina Colombo, Francesco Benedetti · 2020 · Frontiers in Psychiatry
  70. Dendritic Cells: Neglected Modulators of Peripheral Immune Responses and Neuroinflammation in Mood Disorders?
    Rafael Leite Dantas, Jana Freff, Oliver Ambrée, Eva Carolina Beins, Andreas J. Forstner, Udo Dannlowski, Bernhard Theodor Baune, Stefanie Scheu, Judith Alferink · 2021 · Cells
  71. THE CORRELATION BETWEEN PSYCHIATRIC DISORDERS AND COVID-19: A NARRATIVE REVIEW
    Yanfei He, Ran Yu, Junlin Ren · 2021 · Psychiatria Danubina
  72. Interrelationships Between Oxidative Stress, Cytokines, and Psychotic Symptoms and Executive Functions in Patients With Chronic Schizophrenia
    Zhi Wei Wu, Hong Yu, Xuan Wang, Heng Yong Guan, Mei Hong Xiu, Xiangyang Zhang · 2021 · Psychosomatic Medicine
  73. Impact of polyphenols on stress and anxiety: a systematic review of molecular mechanisms and clinical evidence
    Gabriela Paz Pizarro Meléndez, Viviana Valero-Jara, Paula Acevedo-Hernández, Samanta Thomas‐Valdés · 2022 · Critical Reviews in Food Science and Nutrition
  74. IL-17 and TNF-β: Predictive biomarkers for transition to psychosis in ultra-high risk individuals
    Lijun Ouyang, David Li, Zongchang Li, Xiaoqian Ma, Yuan Liu, Lejia Fan, Zihao Yang, Zhenmei Zhang, Chunwang Li, Ying Hé et al. · 2022 · Frontiers in Psychiatry
  75. Inflammatory disequilibrium and lateral ventricular enlargement in treatment-resistant schizophrenia
    Wenjin Chen, Mengzhuang Gou, Leilei Wang, Na Li, Wei Li, Jinghui Tong, Yanfang Zhou, Ting Xie, Ting Yu, Wei Feng et al. · 2023 · European Neuropsychopharmacology
  76. Association of Single Nucleotide Polymorphisms of Cytokine Genes with Depression, Schizophrenia and Bipolar Disorder
    Михалицкая Екатерина Викторовна, Natalya M. Vyalova, Evgeny A. Ermakov, Lyudmila A. Levchuk, German G. Simutkin, Nikolay A. Bokhan, Svetlana А. Ivanova · 2023 · Genes
  77. Long-term exposure to ambient air pollution, genetic susceptibility, and the incidence of bipolar disorder: A prospective cohort study
    Dankang Li, Yudiyang Ma, Feipeng Cui, Yingping Yang, Run Liu, Linxi Tang, Jianing Wang, Yaohua Tian · 2023 · Psychiatry Research
  78. HERV-W upregulation expression in bipolar disorder and schizophrenia: unraveling potential links to systemic immune/inflammation status
    Sara Coelho Rangel, Michelly Damasceno da Silva, Décio Gilberto Natrielli Filho, Samuel Nascimento Santos, Jônatas Bussador do Amaral, Jefferson Russo Victor, Kevin Cézar Nascimento Silva, Izabela Tuleta, Carolina Nunes França, Marina Tiemi Shio et al. · 2024 · Retrovirology
  79. Peripheral biomarker signatures of bipolar disorder and schizophrenia: A machine learning approach
    Jairo Vinícius Pinto, Ives Cavalcante Passos, Fernando Grilo Gomes, Ramiro de Freitas Xavier Reckziegel, Flávio Pereira Kapczinski, Benson Mwangi, Marcia Kauer‐Sant’Anna · 2017 · Schizophrenia Research
  80. Tumour necrosis factor-mediated homeostatic synaptic plasticity in behavioural models: testing a role in maternal immune activation
    Sarah Konefal, David Stellwagen · 2017 · Philosophical Transactions of the Royal Society B Biological Sciences
  81. Leukocytes in peripheral blood in patients with bipolar disorder – Trait and state alterations and association with levels of cytokines and C-reactive protein
    Munkholm, Klaus, Jacoby, Anne Sophie, Lenskjold, Toke, Bruunsgaard, Helle, Vinberg, Maj, Kessing, Lars Vedel · 2018 · Psychiatry Research
  82. Impact of antidepressant treatment on complete blood count parameters and inflammatory ratios in adolescents with major depressive disorder
    Puangsri, Pavarud, Jinanarong, Vinn, Ninla-aesong, Putrada · 2023 · Journal of Psychiatric Research
  83. Immunoinflammatory and oxidative alterations in subjects with schizophrenia under clozapine: A meta-analysis
    Paulo Levi Bezerra Martins, Ian A. Moura, Gabrielle Mendes, Vitória Cristina Almeida Flexa Ribeiro, André Arnaud, Clarissa Severino Gama, Michael H. J. Maes, Danielle S. Macêdo, Joel Porfírio Pinto · 2023 · European Neuropsychopharmacology
  84. The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia
    Melanie M. Ashton, Olivia May Dean, Adam J. Walker, Chiara C. Bortolasci, Chee H. Ng, Malcolm Hopwood, Brian Herbert Harvey, Marisa Möller, John Joseph McGrath, Wolfgang Marx et al. · 2019 · Frontiers in Psychiatry
  85. Biological and Psychological Stress Correlates Are Linked to Glucose Metabolism, Obesity, and Gender Roles in Women
    Alexander Kautzky, Kathrin Heneis, Karin Stengg, Sabine Fröhlich, Alexandra Kautzky‐Willer · 2021 · Neuroendocrinology
  86. Brain morphology is differentially impacted by peripheral cytokines in schizophrenia-spectrum disorder
    Liliana Laskaris, Serafino G. Mancuso, Cynthia Shannon Weickert, Andrew Zalesky, Gursharan Chana, Cassandra Wannan, Chad Bousman, Bernhard Theodor Baune, Patrick D. McGorry, Christos Pantelis et al. · 2021 · Brain Behavior and Immunity
  87. Increased activation product of complement 4 protein in plasma of individuals with schizophrenia
    Agnieszka Kalinowski, Joanna Liliental, Lauren A. Anker, Omer Linkovski, Collin J. Culbertson, Jacob N. Hall, Reenal Pattni, Chiara Sabatti, Douglas L. Noordsy, Joachim Franz Hallmayer et al. · 2021 · Translational Psychiatry
  88. Peripheral Blood-Based Gene Expression Studies in Schizophrenia: A Systematic Review
    Vipul V. Wagh, Parin Vyas, Suchita Agrawal, Tejaswini A. Pachpor, Vasudeo P. Paralikar, Satyajeet Khare · 2021 · Frontiers in Genetics
  89. Sulforaphane Effects on Cognition and Symptoms in First and Early Episode Schizophrenia: A Randomized Double-Blind Trial
    Gangrui Hei, Robert C. Smith, Ranran Li, Jianjun Ou, Xueqing Song, Yingjun Zheng, Yiqun He, Jen Arriaza, Jed W. Fahey, Brian S. Cornblatt et al. · 2022 · Schizophrenia Bulletin Open
  90. Potential diagnostic biomarkers for schizophrenia
    Weihua Yue, Hailiang Huang, Jubao Duan · 2022 · Medical Review
  91. Increased blood neutrophil extracellular traps (NETs) associated with early life stress: translational findings in recent-onset schizophrenia and rodent model
    Fabiana Maria das Graças Corsi Zuelli, Ayda Henriques Schneider, Thamyris Santos‐Silva, Camila Marcelino Loureiro, Rosana Shuhama, Paulo Rossi Menezes, Francisco Silveira Guimarães, Felipe V. Gomes, Fernando Q. Cunha, Paulo Louzada‐Júnior et al. · 2022 · Translational Psychiatry
  92. Comparisons of 25 cerebrospinal fluid cytokines in a case–control study of 106 patients with recent-onset depression and 106 individually matched healthy subjects
    Nina Vindegaard Sørensen, Nis Borbye‐Lorenzen, Rune Haubo Bojesen Christensen, Sonja Orlovska‐Waast, Rose Jeppesen, Kristin Skogstrand, Michael E. Benros · 2023 · Journal of Neuroinflammation
  93. Peripheral inflammatory subgroup differences in anterior Default Mode network and multiplex functional network topology are associated with cognition in psychosis
    Paulo L. Lizano, Chelsea Kiely, Mite Mijalkov, Shashwath A. Meda, Sarah Keedy, Dung T. Hoang, Victor Zeng, Olivia Lutz, Joana B. Pereira, Elena I. Ivleva et al. · 2023 · Brain Behavior and Immunity
  94. Immune and oxidative stress biomarkers in pediatric psychosis and psychosis-risk: Meta-analyses and systematic review
    Jerome H. Taylor, Julieta Bermúdez-Gómez, Marina Zhou, Óscar Gómez, Casey Ganz-Leary, Cesar Palacios, Zeeshan M. Huque, Ran Barzilay, David R. Goldsmith, Raquel E. Gur · 2023 · Brain Behavior and Immunity
  95. Genetic evidence for causal effects of immune dysfunction in psychiatric disorders: where are we?
    Olena P. Iakunchykova, Esten Høyland Leonardsen, Yunpeng Wang · 2024 · Translational Psychiatry
  96. An Overview of the Potential Role of Nutrition in Mental Disorders in the Light of Advances in Nutripsychiatry
    Nursel Dal, Saniye Bilici · 2024 · Current Nutrition Reports
  97. Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs
    Buranee Kanchanatawan, Sunee Sirivichayakul, Andre Ferrer Carvalho, George Anderson, Piotr Gałecki, Michael H. J. Maes · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  98. The effect of trauma and alcohol on the relationship between level of cytokines and depression among patients entering psychiatric treatment
    Helge Toft, Sudan Prasad Neupane, Jørgen G. Bramness, Terje Tilden, Bruce E. Wampold, Lars Lien · 2018 · BMC Psychiatry
  99. Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression
    Giuseppe Fanelli, Francesco Benedetti, Sheng‐Min Wang, Soo-Jung Lee, Tae‐Youn Jun, Prakash S. Masand, Ashwin A. Patkar, Changsu Han, Alessandro Serretti, Chi‐Un Pae et al. · 2019 · Journal of Affective Disorders
  100. Microbiome‐skin‐brain axis: A novel paradigm for cutaneous wounds
    Yasmin Hadian, Daniel R. Fregoso, Chuong Nguyen, Michelle Dawn Bagood, Sara E. Dahle, Mélanie G. Gareau, R. Rivkah Isseroff · 2020 · Wound Repair and Regeneration